|
|
|
Insider
Information: |
Moore John R |
Relationship: |
|
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
5,415 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$140,530 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
5,415 |
|
|
Total
Value |
$140,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alpine Immune Sciences Inc |
ALPN |
Director |
2015-06-16 |
2,163 |
|
0 |
Premium* |
|
Edgewise Therapeutics, Inc. |
EWTX |
|
2024-05-02 |
3,252 |
2021-12-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALPN |
Alpine Immune Sciences In... |
Director |
|
2015-06-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,163 |
|
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-07-06 |
4 |
AS |
$8.54 |
$8,928 |
D/D |
(1,046) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-07-06 |
4 |
OE |
$1.93 |
$2,019 |
D/D |
1,046 |
4,046 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2023-05-02 |
4 |
S |
$8.90 |
$16,893 |
D/D |
(1,897) |
6,565 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-05-02 |
4 |
S |
$18.91 |
$36,988 |
D/D |
(1,956) |
3,252 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-14 |
4 |
AS |
$6.02 |
$21,855 |
D/D |
(3,628) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-14 |
4 |
OE |
$0.71 |
$2,576 |
D/D |
3,628 |
6,628 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-02-08 |
4 |
OE |
$1.93 |
$7,359 |
D/D |
3,813 |
3,813 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-02-08 |
4 |
AS |
$20.01 |
$76,285 |
D/D |
(3,813) |
0 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-13 |
4 |
OE |
$0.71 |
$2,906 |
D/D |
4,093 |
7,093 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-13 |
4 |
AS |
$6.01 |
$24,582 |
D/D |
(4,093) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-09-06 |
4 |
OE |
$1.93 |
$9,129 |
D/D |
4,730 |
7,730 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-09-06 |
4 |
AS |
$10.83 |
$51,598 |
D/D |
(4,730) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-10-03 |
4 |
OE |
$1.93 |
$9,129 |
D/D |
4,730 |
7,730 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-10-03 |
4 |
AS |
$9.76 |
$46,155 |
D/D |
(4,730) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2023-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
8,462 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
5,208 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2021-12-28 |
4 |
OE |
$0.71 |
$3,834 |
D/D |
5,400 |
6,962 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-01-21 |
4 |
OE |
$0.71 |
$3,834 |
D/D |
5,400 |
12,362 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-10 |
4 |
OE |
$0.71 |
$5,059 |
D/D |
7,125 |
10,125 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-10 |
4 |
AS |
$6.05 |
$43,120 |
D/D |
(7,125) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-09 |
4 |
AS |
$6.49 |
$49,397 |
D/D |
(7,615) |
3,000 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2022-06-09 |
4 |
OE |
$0.71 |
$5,407 |
D/D |
7,615 |
10,615 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-02-09 |
4 |
AS |
$20.01 |
$160,657 |
D/D |
(8,029) |
0 |
0 |
- |
|
EWTX |
Edgewise Therapeutics, In... |
General Counsel |
|
2024-02-09 |
4 |
OE |
$1.93 |
$15,496 |
D/D |
8,029 |
8,029 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|